知镜 Cognispect · 医学文献与研究工作台

Lactate Homeostasis Disruption Potentiates TACE-Immunotherapy in Hepatocellular Carcinoma.

Chen M, Chen X, Yang B, Xu H, Sun X, Qi H, Hu H, Wu R, Qiu F, Wu B, Luo Y, Shu G, Ji J.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026-10-28 · PMID 42949602

文献摘要

Developing strategies that simultaneously overcome chemoresistance and immune suppression remains a major challenge for improving transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC). Inspired by clinically used CaCO 3 microspheres in TACE, we propose an "extracellular buffering-intracellular metabolic disruption" strategy to precisely regulate lactate homeostasis for targeted therapy. Herein, we engineered multifunctional embolic microspheres (SDCa-MSs) co-loaded with calcium carbonate nanoparticles (CaNPs), syrosingopine (Syr), and doxorubicin (DOX) for TACE application. Within the acidic tumor microenvironment, SDCa-MSs buffer extracellular acidity while disrupting intracellular lactate metabolism, thereby simultaneously remodeling extracellular and intracellular pH homeostasis. This coordinated regulation enhances DOX efficacy, induces calcium dyshomeostasis and immunogenic cell death, and ultimately stimulates robust antitumor immunity. In multiple murine HCC models, SDCa-MSs markedly suppress tumor growth, remodel the tumor immune microenvironment, and synergistically enhance the therapeutic efficacy of anti-PD-L1 immunotherapy. By integrating metabolic regulation, chemotherapy, and immune activation into a single embolic platform, this work establishes an acid-base homeostasis-regulating strategy for potentiating TACE and provides a conceptual framework for improving locoregional cancer immunotherapy.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。